Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$1.14B |
| 2 |
UnitedHealth
UNH
|
+$391M |
| 3 |
Meta Platforms (Facebook)
META
|
+$310M |
| 4 |
Wabtec
WAB
|
+$296M |
| 5 |
Elanco Animal Health
ELAN
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$518M |
| 2 |
Coca-Cola
KO
|
+$358M |
| 3 |
ATHN
Athenahealth, Inc.
ATHN
|
+$323M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$303M |
| 5 |
Starbucks
SBUX
|
+$288M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 17.92% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 11.03% |
| 5 | Consumer Discretionary | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Honeywell
HON
$77.9B
| $195M | 0.11% |
1,303,952
+10,909
| +0.8% | +$1.52M |
|
227
Fortinet
FTNT
$112B
| $194M | 0.11% |
11,577,300
-283,175
| -2% | -$4.51M |
|
228
Williams-Sonoma
WSM
$27.6B
| $191M | 0.11% |
6,802,392
-410,976
| -6% | -$11.3M |
|
229
ITT
ITT
$17.7B
| $189M | 0.1% |
3,264,096
-34,017
| -1% | -$1.86M |
|
230
Jack Henry & Associates
JKHY
$10.9B
| $188M | 0.1% |
1,357,658
-38,246
| -3% | -$5.06M |
|
|
EQC
231
DELISTED
Equity Commonwealth
EQC
| $188M | 0.1% |
5,747,070
-104,698
| -2% | -$3.36M |
|
|
RTN
232
DELISTED
Raytheon Company
RTN
| $188M | 0.1% |
1,030,871
-782,054
| -43% | -$136M |
|
|
ABMD
233
DELISTED
Abiomed Inc
ABMD
| $186M | 0.1% |
652,554
-69,412
| -10% | -$23.1M |
|
234
Dollar Tree
DLTR
$24.1B
| $186M | 0.1% |
1,773,585
-53,810
| -3% | -$5.28M |
|
235
CBRE Group
CBRE
$42.1B
| $185M | 0.1% |
3,742,550
-842
| -0% | -$39.5K |
|
236
Occidental Petroleum
OXY
$54.6B
| $182M | 0.1% |
2,750,590
-83,183
| -3% | -$5.48M |
|
237
ExxonMobil
XOM
$642B
| $181M | 0.1% |
2,234,620
+30,901
| +1% | +$2.36M |
|
|
ALXN
238
DELISTED
Alexion Pharmaceuticals
ALXN
| $179M | 0.1% |
1,325,355
+303,359
| +30% | +$37.7M |
|
239
Ryanair
RYAAY
$29.8B
| $178M | 0.1% |
5,940,148
-20,867
| -0.4% | -$605K |
|
240
Regeneron Pharmaceuticals
REGN
$69.9B
| $177M | 0.1% |
430,152
-505,998
| -54% | -$208M |
|
|
TSS
241
DELISTED
Total System Services, Inc.
TSS
| $176M | 0.1% |
1,852,485
-794,623
| -30% | -$71.8M |
|
|
PPL
242
PPL Corp
PPL
$27.1B
| $175M | 0.1% |
5,518,786
+808,535
| +17% | +$25.1M |
|
243
Rogers Corp
ROG
$2.31B
| $174M | 0.1% |
1,095,998
-42,643
| -4% | -$5.76M |
|
244
Ligand Pharmaceuticals
LGND
$5.96B
| $174M | 0.1% |
2,220,261
+635,054
| +40% | +$48.1M |
|
245
Equity Lifestyle Properties
ELS
$12.6B
| $174M | 0.1% |
3,039,904
-477,730
| -14% | -$25.6M |
|
246
Walmart Inc
WMT
$889B
| $173M | 0.1% |
5,330,706
+75,468
| +1% | +$2.45M |
|
247
DexCom
DXCM
$28.3B
| $173M | 0.1% |
5,809,940
+821,608
| +16% | +$28.9M |
|
248
Etsy
ETSY
$7.96B
| $172M | 0.1% |
2,559,151
-740,168
| -22% | -$44.2M |
|
249
Xcel Energy
XEL
$50.4B
| $172M | 0.1% |
3,059,624
+680,277
| +29% | +$36.2M |
|
250
Allstate
ALL
$67.3B
| $171M | 0.09% |
1,818,563
-510,306
| -22% | -$46.2M |
|
Similar funds
Janus Henderson Group's Q1 2019 Portfolio in Review
As of Q1 2019, Janus Henderson Group held 1,435 positions worth $180B, up 15% from $157B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Janus Henderson Group's Q1 2019 filing shows 105 new, 637 increased, 574 reduced and 94 closed positions. Its largest new stake was Magellan Midstream Partners, L.P.: 1,610,557 shares worth $97.6M. The largest sale was Celgene Corp, an estimated $518M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q1 2019 buy was Magellan Midstream Partners, L.P.: 1,610,557 shares worth $97.6M.
- Janus Henderson Group added most to Walt Disney in Q1 2019, an estimated $1.14B increase.
- Janus Henderson Group's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $518M.
- Janus Henderson Group fully exited Athenahealth, Inc. in Q1 2019, selling an estimated $323M.
- Janus Henderson Group's ten largest holdings make up 17% of its $180B portfolio in Q1 2019.
- Janus Henderson Group opened 105 new positions and closed 94 in Q1 2019.
- Janus Henderson Group's portfolio value rose 15% quarter-over-quarter to $180B.
Based on Janus Henderson Group's 13F filing for Q1 2019, filed 30 Apr 2019.